Trevi Therapeutics provides update on Haduvio’s clinical development program
PremiumThe FlyTrevi Therapeutics provides update on Haduvio’s clinical development program
1M ago
Closing Bell Movers: Ultragenyx Pharmaceutical slips 2% on study update
Premium
The Fly
Closing Bell Movers: Ultragenyx Pharmaceutical slips 2% on study update
1M ago
Trevi Therapeutics Announces Executive Team Changes and Haduvio Progress
Premium
Company Announcements
Trevi Therapeutics Announces Executive Team Changes and Haduvio Progress
1M ago
Trevi initiated with Outperform on cough potential at Raymond James
PremiumThe FlyTrevi initiated with Outperform on cough potential at Raymond James
2M ago
Trevi Therapeutics initiated with an Outperform at Raymond James
Premium
The Fly
Trevi Therapeutics initiated with an Outperform at Raymond James
2M ago
Trevi Therapeutics initiated with a Buy at H.C. Wainwright
Premium
The Fly
Trevi Therapeutics initiated with a Buy at H.C. Wainwright
2M ago
Trevi Therapeutics management to meet virtually with B. Riley
PremiumThe FlyTrevi Therapeutics management to meet virtually with B. Riley
4M ago
Trevi Therapeutics management to meet virtually with B. Riley
Premium
The Fly
Trevi Therapeutics management to meet virtually with B. Riley
4M ago
Trevi Therapeutics initiated with a Buy at Rodman & Renshaw
Premium
The Fly
Trevi Therapeutics initiated with a Buy at Rodman & Renshaw
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100